Literature DB >> 15633120

Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States.

Constance E Ruhl1, James E Everhart.   

Abstract

BACKGROUND & AIMS: Based on experimental and epidemiologic studies, we investigated whether coffee and caffeine consumption reduced the risk of elevated alanine aminotransferase (ALT) activity in persons at high risk for liver injury in a national, population-based study.
METHODS: Participants were 5944 adults in the Third US National Health and Nutrition Examination Survey, 1988-1994, with excessive alcohol consumption, viral hepatitis, iron overload, overweight, or impaired glucose metabolism. Liver injury was indicated by abnormal serum ALT activity (>43 U/L).
RESULTS: Elevated ALT activity was found in 8.7% of this high-risk population. In unadjusted analysis, lower ALT activity was associated with increasing consumption of coffee ( P = .001) and caffeine ( P = .001). Multivariate logistic regression analyses showed that the risk of elevated ALT activity declined with increasing intake of coffee ( P for trend = .034) and caffeine ( P < .001). Comparing persons who drank more than 2 cups per day with noncoffee drinkers, the odds ratio was .56 (95% confidence interval, .31-1.0). Comparing persons in the highest caffeine quintile with the lowest, the odds ratio was .31 (95% confidence interval, .16-.61). These relationships were consistent across subgroups at risk for liver injury and were relatively unchanged when analyses included the entire population or when limited to persons without impaired liver function or right upper quadrant pain. Fasting insulin concentrations did not mediate the effects.
CONCLUSIONS: In this large, national, population-based study, among persons at high risk for liver injury, consumption of coffee and especially caffeine was associated with lower risk of elevated ALT activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633120     DOI: 10.1053/j.gastro.2004.09.075

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  60 in total

1.  Lifestyle Interventions Beyond Diet and Exercise for Patients With Nonalcoholic Fatty Liver Disease.

Authors:  James Philip Esteban; Amreen Dinani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-03

2.  Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males.

Authors:  T Imatoh; S Tanihara; M Miyazaki; Y Momose; Y Uryu; H Une
Journal:  Eur J Nutr       Date:  2010-10-16       Impact factor: 5.614

Review 3.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

4.  The association of low serum alanine aminotransferase activity with mortality in the US population.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Am J Epidemiol       Date:  2013-09-26       Impact factor: 4.897

Review 5.  Interaction between hepatitis C virus and metabolic factors.

Authors:  Yasunori Kawaguchi; Toshihiko Mizuta
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

6.  Liver fibrosis scores predict liver disease mortality in the United States population.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Hepatology       Date:  2017-05-16       Impact factor: 17.425

Review 7.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

8.  Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.

Authors:  Huafeng Shen; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2016-08       Impact factor: 3.062

Review 9.  Coffee and Liver Disease.

Authors:  Manav Wadhawan; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

10.  How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations.

Authors:  Jonathan A Dranoff; Jordan J Feld; Elise G Lavoie; Michel Fausther
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.